RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting by Healer, J, Thompson, JK, Mackwell, KL, Browne, CD, Seager, BA, Ngo, A, Lowes, KN, Silk, SE, Pulido, D, King, LDW, Christen, JM, Noe, AR, Kotraiah, V, Masendycz, PJ, Rajagopalan, R, Lucas, L, Stanford, MM, Soisson, L, Diggs, C, Miller, R, Youll, S, Wycherley, K, Draper, SJ, Cowman, AF

Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex by Williams, BG, King, LDW, Pulido, D, Quinkert, D, Lias, AM, Silk, SE, Ragotte, RJ, Davies, H, Barrett, JR, McHugh, K, Rigby, CA, Alanine, DGW, Barfod, L, Shea, MW, Cowley, LA, Dabbs, RA, Pattinson, DJ, Douglas, AD, Lyth, OR, Illingworth, JJ, Jin, J, Carnrot, C, Kotraiah, V, Christen, JM, Skinner, K, Higgins, MK, Draper, SJ